A clinical study to determine the efficacy and safety of MK0869 in the treatment of depression
The duration of treatment is 8 weeks.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
600
HAMD-17 total score at week 8. Tolerability.
Time frame: at week 8
CGI-I Scale score at week 8 and Sheehan Disability Scale at week 8
Time frame: at week 8
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.